Metrikler
Yayın
213
Açık Erişim
1
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (142)
SCI-E, SSCI, AHCI (125)
SCI-E, SSCI, AHCI, ESCI (127)
ESCI (2)
Scopus (122)
TRDizin (4)
Diğer Yayınlar (13)
2025
20251. Can we cure Behçet syndrome?
Yazici H., HATEMİ G., Yazici Y.
Current Opinion in Immunology
, cilt.95, 2025 (SCI-Expanded)
2023
20232. A probable ecologic bias in the article on the progression of knee osteoarthritis: comment on the article by Lo et al
Yazici H., Ogun H., Yazici Y.
ARTHRITIS & RHEUMATOLOGY
, cilt.75, ss.1683-0, 2023 (SCI-Expanded)
2023
20233. Infliximab for vascular involvement in Behcet's syndrome
HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., UYGUNOĞLU U., et al.
CLINICAL IMMUNOLOGY
, cilt.253, 2023 (SCI-Expanded)
2022
20224. Frequency of AA amyloidosis has decreased in Behcet's syndrome: a retrospective study with long-term follow-up and a systematic review Amyloidosis in Behcet's syndrome
Karatemiz G., ESATOĞLU S. N., Gurcan M., ÖZGÜLER Y., Yurdakul S., HAMURYUDAN V., et al.
RHEUMATOLOGY
, cilt.62, ss.9-18, 2022 (SCI-Expanded)
2022
20225. Outcome of Vascular Involvement of Behcet Syndrome Treated with Infliximab: A Retrospective Cohort Study
HATEMİ G., Tukek N. B., ESATOĞLU S. N., ÖZGÜLER Y., Taflan S. S., MELİKOĞLU M., et al.
ARTHRITIS & RHEUMATOLOGY
, ss.3098-3099, 2022 (SCI-Expanded)
2022
20226. Emergence of new manifestations during infliximab treatment in Behcet's syndrome
TÜKEK N. B., ESATOĞLU S. N., HATEMİ G., Caliskan E. B., Ozyazgan Y., UÇAR D., et al.
RHEUMATOLOGY
, cilt.61, sa.9, ss.3746-3753, 2022 (SCI-Expanded)
2022
20227. Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
Ozdede A., Yazici H.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.386, sa.18, ss.1766, 2022 (SCI-Expanded)
2022
20228. Core Set of Domains for Outcome Measures in Behcet's Syndrome
HATEMİ G., Meara A., Ozguler Y., DİRESKENELİ R. H., Mahr A., Shea B., et al.
ARTHRITIS CARE & RESEARCH
, cilt.74, ss.691-699, 2022 (SCI-Expanded)
2021
20219. Behcet syndrome
Yazici Y., HATEMİ G., Bodaghi B., Cheon J. H., Suzuki N., Ambrose N., et al.
NATURE REVIEWS DISEASE PRIMERS
, cilt.7, sa.1, 2021 (SCI-Expanded)
2021
202110. The winter of my discontent
Yazici H.
TURKISH ARCHIVES OF PEDIATRICS
, cilt.56, sa.3, ss.177-178, 2021 (ESCI)
2020
202011. Long term follow-up of Behcet's syndrome patients treated with cyclophosphamide
Gurcan M., Esatoglu S. N., HAMURYUDAN V., Saygin D., UĞURLU S., SEYAHİ E., et al.
RHEUMATOLOGY
, cilt.59, sa.9, ss.2264-2271, 2020 (SCI-Expanded)
2020
202012. The P-value crisis and the issue of causality
Yazici H.
RHEUMATOLOGY
, cilt.59, sa.7, ss.1467-1468, 2020 (SCI-Expanded)
2020
202013. Comment on: Clinical course of acute deep vein thrombosis of the legs in Behcet's syndrome: reply
ÖZGÜLER Y., HATEMİ G., Cetinkaya F., Tascilar K., HAMURYUDAN V., UĞURLU S., et al.
RHEUMATOLOGY
, cilt.59, sa.4, ss.914-915, 2020 (SCI-Expanded)
2020
202014. Clinical course of acute deep vein thrombosis of the legs in Behcet's syndrome
ÖZGÜLER Y., HATEMİ G., Cetinkaya F., Tascilar K., HAMURYUDAN V., UĞURLU S., et al.
RHEUMATOLOGY
, cilt.59, sa.4, ss.799-806, 2020 (SCI-Expanded)
2019
201915. Increased vein wall thickness in Behcet disease
Seyahi E., Gjoni M., Durmaz E. S., Akbas S., SÜT N., Dikici A. S., et al.
JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS
, cilt.7, sa.5, ss.677-686, 2019 (SCI-Expanded)
2019
201916. Assessment of deep venous thrombosis in the lower extremity in Behcet's syndrome: MR venography versus Doppler ultrasonography
Tutar B., Kantarci F., Cakmak O. S., Yazici H., Seyahi E.
INTERNAL AND EMERGENCY MEDICINE
, cilt.14, sa.5, ss.705-711, 2019 (SCI-Expanded)
2018
201817. Clinical Characteristics of Older Age-Onset Behcet Syndrome Patients
Guzelant G., Ozyazgan Y., Mat C., Hamuryudan V., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded)
2018
201818. Acknowledged Biostatistical Help and the Quality of Statistical Analyses in Randomized Controlled Trials in Rheumatology
Dincses E., Guzelant G., Hatemi G., Yazici H.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded)
2018
201819. Retrospective Analysis of Initial Presentation Findings of Behcet's Syndrome throughout 4 Decades
Dincses E., Ozguler Y., Ucar D., Ozyazgan Y., Ugurlu S., Hatemi G., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.70, 2018 (SCI-Expanded)
2018
201820. Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration
Ozguler Y., Yazici Y., Hatemi G., Tascilar K., Yazici H.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
, cilt.27, sa.8, ss.894-901, 2018 (SCI-Expanded)
2018
201821. Behcet syndrome: a contemporary view
Yazici H., Seyahi E., Hatemi G., Yazici Y.
NATURE REVIEWS RHEUMATOLOGY
, cilt.14, sa.2, ss.107-119, 2018 (SCI-Expanded)
2017
201722. Developing a Core Set of Outcome Measures for Behcet Disease: Report from OMERACT 2016
Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Easley E., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.44, sa.11, ss.1750-1753, 2017 (SCI-Expanded)
2017
201723. Cardiovascular Risk Factors and Comorbid Diseases in Takayasu's Arteritis
Masyan H., Esatoglu S. N., Celik A. M., Hamuryudan V., Yazici H., Seyahi E.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded)
2017
201724. Surgical Therapies in the Treatment of Pulmonary Artery Involvement in Behcet's Syndrome
Tuzun H., Guzelant G., Demirhan O., Oz B., Fresko I., Hamuryudan V., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, 2017 (SCI-Expanded)
2017
201725. Missing Information About Disease Controls: Comment on the Article by Mangnus et al
Esatoglu S. N., Seyahi E., Yazici H.
ARTHRITIS & RHEUMATOLOGY
, cilt.69, sa.3, ss.678, 2017 (SCI-Expanded)
2016
201626. Identifying Core Domains for BehcEt's Syndrome Trials: An International Physician and Patient Delphi Exercise
Meara A., Ozguler Y., Mahr A., Direskeneli H., Gül A., Yazici Y., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded)
2016
201627. a Systematic Literature Review on the Treatment of Skin, Mucosa and Joint Involvement of BehcEt's Syndrome Informing the Eular Recommendations for the Management of BehcEt's Syndrome
Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Bang D., Bodaghi B., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.68, 2016 (SCI-Expanded)
2016
201628. Diagnostic criteria as separate from classification criteria: a perpetual motion machine? Comment on the article by Aggarwal et al
Yazici H., Hatemi G., Yazici Y.
ARTHRITIS CARE & RESEARCH
, cilt.68, sa.7, ss.1049, 2016 (SCI-Expanded)
2016
201629. Behcet syndrome: the vascular cluster
Yazici H., Seyahi E.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.46, sa.5, ss.1277-1280, 2016 (SCI-Expanded)
2015
201530. Current Status, Goals, and Research Agenda for Outcome Measures Development in Behcet Syndrome: Report from OMERACT 2014
Hatemi G., Ozguler Y., Direskeneli H., Mahr A., Gul A., Levı V., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.42, ss.2436-2441, 2015 (SCI-Expanded)
2015
201531. Assessing the Possible Association of Anti-TNF Use with New Neoplasms: An Important Methodological Consideration
Ozguler Y., Yazici Y., Hatemi G., Yazici H.
ARTHRITIS & RHEUMATOLOGY
, cilt.67, 2015 (SCI-Expanded)
2014
201432. Are sample sizes of randomized clinical trials in rheumatoid arthritis too large?
Celik S., Yazici Y., Yazici H.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
, cilt.44, sa.11, ss.1034-1044, 2014 (SCI-Expanded)
2014
201433. Budd-Chiari Syndrome Due to Behcet's Syndrome: Some Patients Present without Liver Related Symptoms and Have a Better Outcome.
Seyahi E., Caglar E., Ugurlu S., Kantarci F., Hamuryudan V., Sonsuz A., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded)
2014
201434. Anti-TNF Treatment for Refractory Vascular Involvement of Behcet's Syndrome.
Hamuryudan V., Seyahi E., Melikoglu M., Ugurlu S., Hatemi G., Yurdakul S., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded)
2014
201435. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.
Melikoglu M., Ozguler Y., Ugurlu S., Cetinkaya F., Tascilar K., Seyahi E., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded)
2014
201436. Interferon Alfa-Associated Depression in Patients with Behcet's Syndrome.
Keskin Y., Seyahi E., Poyraz C., Ugurlu S., Ozyazgan Y., Yazici H.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded)
2014
201437. Effect of Apremilast on Quality of Life and Physical Function in Patients with Behcet's Syndrome.
Hatemi G., Melikoglu M., Tunc R., Korkmaz C., ÖZTÜRK B. T., Mat C., et al.
ARTHRITIS & RHEUMATOLOGY
, cilt.66, 2014 (SCI-Expanded)
2014
201438. There was less self-critique among basic than in clinical science articles in three rheumatology journals
Yazici H., Gogus F., Esen F., Yazici Y.
JOURNAL OF CLINICAL EPIDEMIOLOGY
, cilt.67, sa.6, ss.654-657, 2014 (SCI-Expanded)
2014
201439. No appreciable decrease in fertility in Behcet's syndrome
Uzunaslan D., Saygin C., Hatemi G., Tascilar K., Yazici H.
RHEUMATOLOGY
, cilt.53, sa.5, ss.828-833, 2014 (SCI-Expanded)
2014
201440. Outcome Measures Used in Clinical Trials for Behcet Syndrome: A Systematic Review
Hatemi G., Merkel P. A., Hamuryudan V., Boers M., Direskeneli H., Aydin S. Z., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.41, sa.3, ss.599-612, 2014 (SCI-Expanded)
2014
201441. Criteria for Behcet's disease with reflections on all disease criteria
Yazici H., Yazici Y.
JOURNAL OF AUTOIMMUNITY
, ss.104-107, 2014 (SCI-Expanded)
2014
201442. The Clinical Course of Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome
Ozguler Y., Melikoglu M., Ugurlu S., Cetinkaya F., Tascilar E. K., Seyahi E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.32, sa.4, 2014 (SCI-Expanded)
2013
201343. Tuberculosis Screening Before and During Treatment with Tumor Necrosis Factor Antagonists: Something Old, Something New
Hatemi G., Yazici H.
JOURNAL OF RHEUMATOLOGY
, cilt.40, sa.12, ss.1938-1940, 2013 (SCI-Expanded)
2013
201344. Neoplasms as the leading cause of death among patients with rheumatoid arthritis receiving tumor necrosis factor inhibitors: comment on the article by Simard et al
Yazici H., Tascilar K., Yazici Y.
ARTHRITIS AND RHEUMATISM
, cilt.65, sa.6, ss.1670, 2013 (SCI-Expanded)
2012
201245. Are we content that risk of cancer is not appreciably increased after tumor necrosis factor inhibitor use? Comment on the article by Solomon et al
Yazici H., Yazici Y.
ARTHRITIS AND RHEUMATISM
, cilt.64, sa.7, ss.2414, 2012 (SCI-Expanded)
2012
201246. The papulopustular lesion/arthritis cluster of Behcet's syndrome also clusters in families
Karaca M., Hatemi G., SÜT N., Yazici H.
RHEUMATOLOGY
, cilt.51, sa.6, ss.1053-1060, 2012 (SCI-Expanded)
2011
201147. New evidence for the role of interferon regulatory factor 5 in the development of systemic lupus erythematosus: comment on the article by Tada et al
Yazici H., Tascilar K., Kiroglu G., Erar A., DURANSOY M. L.
ARTHRITIS AND RHEUMATISM
, cilt.63, sa.8, ss.2543-2544, 2011 (SCI-Expanded)
2011
201148. A proposal from Istanbul University for a new legislation on higher education
Batmaz V., Ozturk R., Vardar O., Yanik M., Yarman S., Yazici H.
YUKSEKOGRETIM DERGISI
, cilt.1, sa.1, ss.6-7, 2011 (ESCI)
2011
201149. Behcet's syndrome and micro-organisms
Hatemi G., Yazici H.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
, cilt.25, sa.3, ss.389-406, 2011 (SCI-Expanded)
2011
201150. Behcet's Syndrome: Clinical Presentations Affecting Prognosis and Survival
Seyahi E., Tascilar K., Yazici H.
AUTOIMMUNE DISEASES: ACUTE AND COMPLEX SITUATIONS
, ss.163-184, 2011 (SCI-Expanded)
2010
201051. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis
Basu N., Watts R., Bajema I., Baslund B., Bley T., Boers M., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.69, sa.10, ss.1744-1750, 2010 (SCI-Expanded)
2010
201052. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME (BS)
Hamuryudan V., Hatemi G., Yurdakul S., Tascilar K., Mat C., Ozyazgan Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201053. EYE DISEASE IN JUVENILE PATIENTS WITH BEHCET'S SYNDROME
Ozyazgan Y., Seyahi E., Sarica A., Ugurlu S., Hatemi G., Yurdakul S., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201054. A TWIN STUDY IN BEHCET'S SYNDROME
Masatlioglu S., Seyahi E., Tahir Turanlı E., Fresko I., Gogus F., Senates E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201055. AN AUDIT OF BEHCET'S SYNDROME RESEARCH: A 10-YEAR SURVEY
Esen F., Schimmel E. K., Yazici H., Yazici Y.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201056. A COMPARATIVE STUDY OF CLINICAL, ENDOSCOPIC AND HISTOLOGIC FINDINGS IN PATIENTS WITH GASTROINTESTINAL BEHCET'S DISEASE AND CROHN'S DISEASE
Celik A. F., Hatemi I., Hatemi G., Satir E., Erzin Y., Sisman G., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201057. CURRENT TRENDS IN THE MANAGEMENT OF BEHCET'S SYNDROME
Hatemi G., Hamuryudan V., Tascilar K., Yurdakul S., Fresko I., Melikoglu M., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201058. PULMONARY ARTERY HYPERTENSION IN BEHCET'S SYNDROME
Seyahi E., Baskurt M., Melikoglu M., Akman C., Cebiolgun D., Simsek E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201059. THE PAPULOPUSTULAR LESION/ARTHRITIS CLUSTER OF BEHCET'S SYNDROME IS INDEPENDENTLY FAMILIAL
Karaca M., Hatemi G., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201060. EFFICACY AND SAFETY OF TNF-ALPHA ANTAGONISTS IN THE MANAGEMENT OF BEHCET'S SYNDROME: A SYSTEMATIC REVIEW
Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.28, sa.4, 2010 (SCI-Expanded)
2010
201061. Interferon therapy in rheumatic diseases: state-of-the-art 2010
Koetter I., Hamuryudan V., Ozturk Z. E., Yazici H.
CURRENT OPINION IN RHEUMATOLOGY
, cilt.22, sa.3, ss.278-283, 2010 (SCI-Expanded)
2010
201062. Comment on: Web resources for rare auto-inflammatory diseases: towards a common patient registry
Yazici Y., Yazici H.
RHEUMATOLOGY
, cilt.49, sa.1, ss.198, 2010 (SCI-Expanded)
2010
201063. Endothelial Dysfunction and Atherosclerosis in Behcet's Syndrome
Seyahi E., Fresko I., Yazici H.
BEHCET'S SYNDROME
, ss.135-148, 2010 (SCI-Expanded)
2010
201064. Informed consent: time for more transparency
Yazici Y., Yazici H.
ARTHRITIS RESEARCH & THERAPY
, cilt.12, sa.3, 2010 (SCI-Expanded)
2010
201065. Introduction: Dedicated Mondays and an Acquaintance-Based View of Behcet's Syndrome
Yazici H.
BEHCET'S SYNDROME
, ss.1-5, 2010 (SCI-Expanded)
2010
201066. Prognosis in Behcet's Syndrome
Seyahi E., Yazici H.
BEHCET'S SYNDROME
, ss.285-298, 2010 (SCI-Expanded)
2009
200967. Low-dose natural human interferon-alpha lozenges in the treatment of Behcet's syndrome
Kilic H., Zeytin H. E., KORKMAZ C., Mat C., Gül A., Cosan F., et al.
RHEUMATOLOGY
, cilt.48, sa.11, ss.1388-1391, 2009 (SCI-Expanded)
2009
200968. Efficacy and safety of TNF-alpha antagonists in the management of Behcet's syndrome - a systematic survey
Hatemi G., Hamuryudan V., Yurdakul S., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.27, sa.5, ss.736, 2009 (SCI-Expanded)
2009
200969. Behcet's syndrome (BS): an update
Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.27, sa.5, ss.730, 2009 (SCI-Expanded)
2009
200970. Common MEFV mutations and polymorphisms in an elderly population: an association with E148Q polymorphism and rheumatoid factor levels
Turanli E. T., Beger T., Erdincler D., Curgunlu A., Karaman S., Karaca E., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.27, sa.2, ss.340-343, 2009 (SCI-Expanded)
2008
200871. Treatment strategies for Behcet's disease
Fresko I., Yazici H.
EXPERT OPINION ON PHARMACOTHERAPY
, cilt.9, sa.18, ss.3211-3219, 2008 (SCI-Expanded)
2008
200872. Comment on "Cardiac Behcet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases"
Hamuryudan V., Seyahi E., Yazici H.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY
, cilt.32, sa.12, ss.1914-1915, 2008 (SCI-Expanded)
2008
200873. Behcet's Syndrome Is Not So Rare: Why Do We Need to Know?
Yazici H., Seyahi E., Yurdakul S.
ARTHRITIS AND RHEUMATISM
, cilt.58, sa.12, ss.3640-3643, 2008 (SCI-Expanded)
2008
200874. The unique features of vasculitis in Behcet's syndrome
Melikoglu M., Kural-Seyahi E., Tascilar K., Yazici H.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
, cilt.35, ss.40-46, 2008 (SCI-Expanded)
2008
200875. Behcet's syndrome
Yurdakul S., Yazici H.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
, cilt.22, sa.5, ss.793-809, 2008 (SCI-Expanded)
2008
200876. Atherosclerosis in Behcet's syndrome
Seyahi E., Ugurlu S., Cumali R., Balci H., Ozdemir O., Melikoglu M., et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM
, cilt.38, sa.1, ss.1-12, 2008 (SCI-Expanded)
2008
200877. THE LONG TERM PROGNOSIS OF BEHCET'S SYNDROME AMONG MEN WITH SKIN-MUCOSA INVOLVEMENT AT ONSET: RE-EVALUATION OF A COHORT OF PATIENTS ENROLLED IN A CONTROLLED TRIAL
Hamuryudan V., Hatemi G., Tascilar K., Ozyazgan Y., Seyahi E., Mat C., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.26, sa.4, 2008 (SCI-Expanded)
2008
200878. PPD REACTION IS NOT AUGMENTED IN BEHCET'S SYNDROME PATIENTS
Hatemi G., Melikoglu M., Sut N., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.26, sa.4, 2008 (SCI-Expanded)
2008
200879. INFLIXIMAB IN 10 PATIENTS WITH BEHCET'S OCULAR INVOLVEMENT
Ozyazgan Y., Sarica A., Seyahi E., Hatemi G., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.26, sa.4, 2008 (SCI-Expanded)
2008
200880. Increased enthesopathy among Behcet's syndrome patients with acne and arthritis
Hatemi G., Fresko I., Tascilar K., Yazici H.
ARTHRITIS AND RHEUMATISM
, cilt.58, sa.5, ss.1539-1545, 2008 (SCI-Expanded)
2007
200781. Intraobserver and interobserver agreements of leg circumference measurements by tape measure based on 3 reference points
Tunc R., Caglayan-Tunc A., Kisakol G., Unler G. K., Hidayetoglu T., Yazici H.
ANGIOLOGY
, cilt.58, sa.5, ss.593-596, 2007 (SCI-Expanded)
2007
200782. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Hellmich B., Flossmann O., Gross W. L., Bacon P., Cohen-Tervaert J. W., Guillevin L., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.66, sa.5, ss.605-617, 2007 (SCI-Expanded)
2007
200783. Infliximab does not suppress the tuberculin skin test (purified protein derivative)
Hatemi G., Melikoglu M., Fresko I., Masatlioglu S., Tascilar K., Yazici H.
JOURNAL OF RHEUMATOLOGY
, cilt.34, sa.3, ss.474-480, 2007 (SCI-Expanded)
2007
200784. Behcet's syndrome: disease manifestations, management, and advances in treatment
Yazici H., Fresko I., Yurdakul S.
NATURE CLINICAL PRACTICE RHEUMATOLOGY
, cilt.3, sa.3, ss.148-155, 2007 (SCI-Expanded)
2006
200685. Characterization of the divergent wound-healing responses occurring in the pathergy reaction and normal healthy volunteers
Melikoglu M., Uysal S., Krueger J. G., Kaplan G., Gogus F., Yazici H., et al.
JOURNAL OF IMMUNOLOGY
, cilt.177, sa.9, ss.6415-6421, 2006 (SCI-Expanded)
2006
200686. Trial of etanercept and methotrexate with radiographic and patient outcomes two-year clinical and radiographic results: Comment on the article by van der Heijde et al
Yazici Y., Yazici H.
ARTHRITIS AND RHEUMATISM
, cilt.54, sa.9, ss.3061-3062, 2006 (SCI-Expanded)
2006
200687. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?
Akman-Demir G., Gul A., Gurol E., Ozdogan H., Bahar S., Oge A. E., et al.
JOURNAL OF NEUROLOGY
, cilt.253, sa.7, ss.928-934, 2006 (SCI-Expanded)
2006
200688. A double-blind trial of depot corticosteroids in Behcet's syndrome
Mat C., Yurdakul S., Uysal S., Gogus F., Ozyazgan Y., Uysal O., et al.
RHEUMATOLOGY
, cilt.45, sa.3, ss.348-352, 2006 (SCI-Expanded)
2005
200589. Fibrinolytic activity and d-dimer levels in Behcet's syndrome
Yurdakul S., Hekim N., Soysal T., Fresko I., Bavunoglu I., Ozbakir F., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.23, sa.4, 2005 (SCI-Expanded)
2005
200590. Short-term trial of etanercept in Behcet's disease: A double blind, placebo controlled study
Melikoglu M., Fresko I., Mat C., Ozyazgan Y., Gogus F., Yurdakul S., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.32, sa.1, ss.98-105, 2005 (SCI-Expanded)
2003
200391. The long-term mortality and morbidity of Behcet syndrome - A 2-decade outcome survey of 387 patients followed at a dedicated center
Kural-Seyahi E., Fresko I., Seyahi N., Ozyazgan Y., Mat C., Hamuryudan V., et al.
MEDICINE
, cilt.82, sa.1, ss.60-76, 2003 (SCI-Expanded)
2002
200292. Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: An open study
Hamuryudan V., Ozyazgan Y., Fresko Y., Mat C., Yurdakul S., Yazici H.
ISRAEL MEDICAL ASSOCIATION JOURNAL
, cilt.4, sa.11, ss.928-930, 2002 (SCI-Expanded)
2001
200193. A double-blind trial of colchicine in Behcet's syndrome
Yurdakul S., Mat C., Tuzun Y., Ozyazgan Y., Hamuryudan V., Uysal O., et al.
ARTHRITIS AND RHEUMATISM
, cilt.44, sa.11, ss.2686-2692, 2001 (SCI-Expanded)
2001
200194. A reassessment of the International Study Group criteria for the diagnosis (classification) of Behcet's syndrome
Tunc R., Uluhan A., Melikoglu M., Ozyazgan Y., Ozdogan H. A., Yazici H.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.19, sa.5, 2001 (SCI-Expanded)
2001
200195. Absence of ANCA in Behcçet’s Syndrome with Large Vessel Involvement
Tunç U., ÖZBAKIR F., Çağlayan A., Altıparmak M., Yargan P., FRESKO İ., et al.
INTERNATIONAL JOURNAL OF ACAROLOGY , cilt.10, ss.260-262, 2001 (Scopus)
1999
199996. Behçet sendromunda antimikobakteriyal antikorlar
MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.
İnfeksiyon Dergisi(Turkish Journal of Infection) , cilt.13, sa.4, ss.527-529, 1999 (Hakemli Dergi)
1999
199997. Neutrophil chemotaxis in Behcet's syndrome
Tüzün B., Tuzun Y., Mat C., Yurdakul S., Hamuryudan V., Yazici H., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.58, sa.10, ss.658, 1999 (SCI-Expanded)
1999
199998. Behcet's syndrome - The cerrahpasa experience
Yazici H., Fresko I., Hamuryudan V., Mat C., Melikoglu M., Ozyazgan Y., et al.
RHEUMADERM
, cilt.455, ss.135-140, 1999 (SCI-Expanded)
1998
199899. Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial
Hamuryudan V., Mat C., Saip S., Ozyazgan Y., Siva A., Yurdakul S., et al.
ANNALS OF INTERNAL MEDICINE
, cilt.128, sa.6, ss.443-451, 1998 (SCI-Expanded)
1998
1998100. Wound healing in Behcet's syndrome
Mat M. C., Nazarbaghi M., Tuzun Y., Hamuryudan V., Hızlı N., Yurdakul S., et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY
, cilt.37, sa.2, ss.120-123, 1998 (SCI-Expanded)
1997
1997101. Azathioprine in Behcet's syndrome - Effects on long-term prognosis
Hamuryudan V., Ozyazgan Y., Hızlı N., Mat C., Yurdakul S., Tuzun Y., et al.
ARTHRITIS AND RHEUMATISM
, cilt.40, sa.4, ss.769-774, 1997 (SCI-Expanded)
1997
1997102. Treatment of Behcet disease with pentoxifylline
Hamuryudan V., Ozyazgan Y., Yazici H.
ANNALS OF INTERNAL MEDICINE
, cilt.126, sa.6, ss.494, 1997 (SCI-Expanded)
1996
1996103. Paterji pozitifliğinin pikür süresi ile ilişkisi
MAT M. C., GÖKLER G., YURDAKUL S., TÜZÜN Y., YAZICI H., HAMURYUDAN V., et al.
CERRAHPAŞA TIP DERGİSİ , cilt.27, ss.94-97, 1996 (Hakemli Dergi)
1996
1996104. The ten-year mortality in Behcet's syndrome
Yazici H., Başaran G., Hamuryudan V., Hızlı N., Yurdakul S., Mat C., et al.
BRITISH JOURNAL OF RHEUMATOLOGY
, cilt.35, sa.2, ss.139-141, 1996 (SCI-Expanded)
1995
1995105. Diabetic sclerodactyly
Tüzün B., Tüzün Y., Dinççağ N., Minareci Ö., Öztürk S., Yilmaz M., et al.
Diabetes Research and Clinical Practice
, cilt.27, sa.2, ss.153-157, 1995 (SCI-Expanded)
1994
1994106. SYSTEMIC INTERFERON-ALPHA-2B TREATMENT IN BEHCETS-SYNDROME
HAMURYUDAN V., Moral F., YURDAKUL S., MAT C., TUZUN Y., OZYAZGAN Y., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.21, sa.6, ss.1098-1100, 1994 (SCI-Expanded)
1994
1994107. Behçet hastalığı
YAZICI H., YURDAKUL S., TÜZÜN Y., ÖZYAZGAN Y., MAT M. C., HAMURYUDAN V.
BİLİM VE TEKNİK , sa.314, ss.25-29, 1994 (Hakemli Dergi)
1993
1993108. URATE CRYSTAL TEST IN BEHCETS-SYNDROME
Çakır N., İmeryüz N., Suna D. C., Gözükara Y., SERDAROGLU S., Mert A., et al.
BRITISH JOURNAL OF RHEUMATOLOGY
, cilt.32, sa.12, ss.1112-1114, 1993 (SCI-Expanded)
1992
1992109. ACUTE FEBRILE NEUTROPHILIC DERMATOSIS (SWEETS SYNDROME) ASSOCIATED WITH BEHCETS-DISEASE
Oğuz O., SERDAROGLU S., TUZUN Y., Erdoğan N., YAZICI H., Savaşkan H.
INTERNATIONAL JOURNAL OF DERMATOLOGY
, cilt.31, sa.9, ss.645-646, 1992 (SCI-Expanded)
1992
1992110. Maffucci sendromu: MR, BT, US, Direkt grafi ve Flebografi özellikleri
KOÇER N., KORMAN M. U., YAZICI H., BERKMEN T., NUMAN F.
Türk Radyoloji Dergisi , sa.27, ss.16-21, 1992 (Hakemli Dergi)
1990
1990111. A CONTROLLED TRIAL OF AZATHIOPRINE IN BEHCETS SYNDROME
YAZICI H., Pazarlı H., Barnes C. G., TUZUN Y., OZYAZGAN Y., Silman A., et al.
NEW ENGLAND JOURNAL OF MEDICINE
, cilt.322, sa.5, ss.281-285, 1990 (SCI-Expanded)
1989
1989112. Paterji testinde pikür derinliği ve dermal travma derecesinin sonuç üzerindeki isi (İntra-epidermal ve dermal paterji uygulaması)
İşçimen A., Tozakı S., SERDAROĞLU S., TÜZÜN Y., YURDAKUL S., Hamuryudan V., et al.
Deri Hast Frengi Arş , cilt.23, ss.175-181, 1989 (Hakemli Dergi)
1989
1989113. PROGNOSTIC VALUE OF HLA B5 ANTIGEN IN ISOLATED ANTERIOR UVEITIS IN BEHCETS-DISEASE
OGUZ V., Pazarlı H., OZYAZGAN Y., YAZICI H., YURDAKUL S., TUZUN Y., et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE
, cilt.12, ss.431-432, 1989 (SCI-Expanded)
1988
1988114. THE HLA ASSOCIATION OF LEPROMATOUS LEPROSY AND BORDERLINE LEPROMATOUS LEPROSY IN TURKEY - A PRELIMINARY-STUDY
MAT M. C., YAZICI H., ÖZBAKIR F., TUZUN Y.
INTERNATIONAL JOURNAL OF DERMATOLOGY
, cilt.27, sa.4, ss.246-247, 1988 (SCI-Expanded)
1988
1988115. THE PREVALENCE OF BEHCET SYNDROME IN A RURAL AREA IN NORTHERN TURKEY
YURDAKUL S., GÜNAYDIN İ., TUZUN Y., TANKURT N., Pazarlı H., OZYAZGAN Y., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.15, sa.5, ss.820-822, 1988 (SCI-Expanded)
1988
1988116. Behçet hastalığında deri belirtileri
TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., İşçimen A., Yurdakul S., Altaç M., et al.
Deri Hast Frengi Arş , cilt.22, ss.29-35, 1988 (Hakemli Dergi)
1987
1987117. SHORT-TERM CYCLOSPORINE-A TREATMENT OF BEHCETS-DISEASE
Müftüoğlu A., Pazarlı H., YURDAKUL S., YAZICI H., Ülkü B. Y., TUZUN Y., et al.
BRITISH JOURNAL OF OPHTHALMOLOGY
, cilt.71, sa.5, ss.387-390, 1987 (SCI-Expanded)
1987
1987118. VONWILLEBRAND-FACTOR IN BEHCETS-SYNDROME
YAZICI H., HEKİM N., ÖZBAKIR F., YURDAKUL S., TUZUN Y., Pazarlı H., et al.
JOURNAL OF RHEUMATOLOGY
, cilt.14, sa.2, ss.305-306, 1987 (SCI-Expanded)
1987
1987119. Behçet hastalığı
YAZICI H., Müftüoğlu A., YURDAKUL S., Ülkü B. Y., TÜZÜN Y., Pazarlı H.
DOĞA , cilt.11, ss.153-169, 1987 (Hakemli Dergi)
1986
1986120. BEHCETS-DISEASE - RELATION OF SERUM C-REACTIVE PROTEIN AND ERYTHROCYTE SEDIMENTATION-RATES TO DISEASE-ACTIVITY
Müftüoğlu A., YAZICI H., YURDAKUL S., TUZUN Y., Pazarlı H., Güngen G., et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY
, cilt.25, sa.4, ss.235-239, 1986 (SCI-Expanded)
1986
1986121. HISTOCOMPATIBILITY ANTIGENS (HLA) IN ACUTE LYMPHOCYTIC-LEUKEMIA
ULUKUTLU L., YAZICI H., CAM H., ESEN E., OZBAKIR F.
TURKISH JOURNAL OF PEDIATRICS
, cilt.28, sa.2, ss.111-114, 1986 (SCI-Expanded)
1986
1986122. Behçet astalığına bağlı göz tutulumlarında görülen klinik tipleri
Pazarlı H., Özyazgan Y., YAZICI H., Bahçecioğlu H., Yurdakul S., Müftüoğlu A., et al.
Deri Hast Frengi Arş , cilt.20, ss.171-174, 1986 (Hakemli Dergi)
1985
1985123. Behçet hastalığı: Damar tutulmasının özellikleri
Müftüoğlu A., YURDAKUL S., YAZICI H., ÖZDOĞAN H., TÜZÜN Y., Pazarlı H., et al.
BAVS VAKIF GUREBA HASTANESİ DERGİSİ , cilt.12, ss.117-124, 1985 (Hakemli Dergi)
1985
1985124. Behçet hastlığı-Damar tutulmasının özellikleri
Müftüoğlu A., YURDAKUL S., YAZICI H., Ozdogan H., TÜZÜN Y., Pazarlı H., et al.
Bezm_i Alem Valide Sultan Vakıf Guraba Hastanesi Dergisi , cilt.12, ss.117-124, 1985 (Hakemli Dergi)
1985
1985125. MALE-PATIENTS WITH BEHCETS SYNDROME HAVE STRONGER PATHERGY REACTIONS
YAZICI H., TUZUN Y., Tanman A. B., YURDAKUL S., SERDAROGLU S., Pazarlı H., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, cilt.3, sa.2, ss.137-141, 1985 (SCI-Expanded)
1984
1984126. A COMPARATIVE-STUDY OF THE PATHERGY REACTION AMONG TURKISH AND BRITISH PATIENTS WITH BEHCETS-DISEASE
YAZICI H., CHAMBERLAIN M., TUZUN Y., YURDAKUL S., Müftüoğlu A.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.43, sa.1, ss.74-75, 1984 (SCI-Expanded)
1984
1984127. INFLUENCE OF AGE OF ONSET AND PATIENTS SEX ON THE PREVALENCE AND SEVERITY OF MANIFESTATIONS OF BEHCETS SYNDROME
YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., OZYAZGAN Y., ÖZDOĞAN H., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.43, sa.6, ss.783-789, 1984 (SCI-Expanded)
1983
1983128. THE ARTHRITIS OF BEHCETS-DISEASE - A PROSPECTIVE-STUDY
YURDAKUL S., YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., ALTAÇ M., et al.
ANNALS OF THE RHEUMATIC DISEASES
, cilt.42, sa.5, ss.505-515, 1983 (SCI-Expanded)
1982
1982129. THE VALIDITY OF THE PATHERGY TEST (NONSPECIFIC SKIN HYPERREACTIVITY) IN BEHCETS-DISEASE - A DOUBLE-BLIND-STUDY BY INDEPENDENT OBSERVERS
ALTAÇ M., TUZUN Y., YURDAKUL S., BİNYILDIZ P., YAZICI H.
ACTA DERMATO-VENEREOLOGICA
, cilt.62, sa.2, ss.158-159, 1982 (SCI-Expanded)
1981
1981130. Kriyoglobulinemi: iki yöntemin kıyaslanması ve Behçet hastalığında kriyoglobulinler
ÖZBAKIR F., YAZICI H., ATAMAN N., Ülkü B. Y., Pazarlı H., TÜZÜN Y., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.12, sa.4, ss.423-427, 1981 (Hakemli Dergi)
1981
1981131. Silivri Fener köyü ve yöresinde Behçet hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem
DEMİRHİNDİ O., YAZICI H., BİNYILDIZ P., DAYIOĞLU N., TÜZÜN Y., ALTAÇ M., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.12, sa.4, ss.509-514, 1981 (Hakemli Dergi)
1981
1981132. İki Yöntemin Kıyaslaması ve Behcet Hastalığında Kriyoglobulinler
ÖZBAKIR F., YAZICI H., Ataman U. K., Yalçın Ülkü P. B., Pazarlı P., Tüzün P. Y., et al.
Cerrahpaşa Tıp Fakültesi Dergisi , cilt.12, sa.3, ss.423-427, 1981 (Hakemli Dergi)
1981
1981133. A METHOD OF MEASURING SKIN-LESIONS
TUZUN Y., YAZICI H.
ARCHIVES OF DERMATOLOGY
, cilt.117, sa.4, ss.192, 1981 (SCI-Expanded)
1981
1981134. BEHCETS-DISEASE - LACK OF CORRELATION OF CLINICAL MANIFESTATIONS WITH HLA ANTIGENS
Müftüoğlu A., YAZICI H., YURDAKUL S., Pazarlı H., OZYAZGAN Y., TUZUN Y., et al.
TISSUE ANTIGENS
, cilt.17, sa.2, ss.226-230, 1981 (SCI-Expanded)
1981
1981135. USEFULNESS OF HLA DETERMINATION AND PATHERGY TEST IN THE DIAGNOSIS OF UVEITIS IN TURKEY
OZYAZGAN Y., Pazarlı H., YAZICI H., YURDAKUL S., TUZUN Y., ALTAÇ M., et al.
BRITISH JOURNAL OF OPHTHALMOLOGY
, cilt.65, sa.11, ss.798-799, 1981 (SCI-Expanded)
1981
1981136. LOCALIZED MYOSITIS IN BEHCETS-DISEASE
YAZICI H., TUZUNER N. N., TUZUN Y., YURDAKUL S.
ARTHRITIS AND RHEUMATISM
, cilt.24, sa.4, ss.636, 1981 (SCI-Expanded)
1980
1980137. Behçet Hastalığı: I. Hematolojik ve immunolojik özellikleri
Müftüoğlu A., Ülkü B. Y., EZER G., GÜRSOY A., YAZICI H., YURDAKUL S., et al.
CERRAHPAŞA TIP FAKÜLTESİ DERGİSİ , cilt.11, sa.3, ss.347-353, 1980 (Hakemli Dergi)
1980
1980138. NONSPECIFIC SKIN HYPER-REACTIVITY IN BEHCETS DISEASE
TUZUN Y., ALTAÇ M., YAZICI H., BAŞÖZ A., YURDAKUL S., Pazarlı H., et al.
HAEMATOLOGICA
, cilt.65, sa.3, ss.395-398, 1980 (SCI-Expanded)
1980
1980139. BEHCETS DISEASE AS SEEN IN TURKEY
YAZICI H., TUZUN Y., Pazarlı H., YURDAKUL S., YALCIN B., Müftüoğlu A.
HAEMATOLOGICA
, cilt.65, sa.3, ss.381-383, 1980 (SCI-Expanded)
1980
1980140. A DOUBLE-BLIND STUDY OF COLCHICINE IN BEHCETS DISEASE
AKTULGA E., ALTAÇ M., Müftüoğlu A., OZYAZGAN Y., Pazarlı H., TUZUN Y., et al.
HAEMATOLOGICA
, cilt.65, sa.3, ss.399-402, 1980 (SCI-Expanded)
1980
1980141. HEMATOLOGICAL AND IMMUNOLOGICAL FEATURES OF BEHCETS DISEASE
YALCIN B., GÜRSOY A., EZER G., Pazarlı H., TUZUN Y., YURDAKUL S., et al.
HAEMATOLOGICA
, cilt.65, sa.3, ss.390-394, 1980 (SCI-Expanded)
1980
1980142. THE COMBINED USE OF HLA-B5 AND THE PATHERGY TEST AS DIAGNOSTIC MARKERS OF BEHCETS-DISEASE IN TURKEY
YAZICI H., TUZUN Y., Pazarlı H., YALCIN B., YURDAKUL S., Müftüoğlu A.
JOURNAL OF RHEUMATOLOGY
, cilt.7, sa.2, ss.206-210, 1980 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
0
01. Sex factor and Behçet's syndrome
YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.
INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, Birleşik Krallık, ss.205, (Tam Metin Bildiri)
2019
20192. FACTORS ASSOCIATED WITH DAMAGE PROGRESSION IN BEHCET'S SYNDROME UVEITIS
Ozyazgan Y., Ucar D., Erdogan M., Ozguler Y., Hatemi G., Yurdakul S., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1187-1188, (Özet Bildiri)
2019
20193. THE OMERACT CORE DOMAIN SET FOR CLINICAL TRIALS IN BEHCET'S SYNDROME
Hatemi G., Meara A., Ozguler Y., Direskeneli H., Mahr A., Shea B., et al.
Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.431, (Özet Bildiri)
2019
20194. HYPERCOAGULABILITY AS A CAUSE OF THROMBOSIS IN BEHCET'S SYNDROME: A SYSTEMATIC REVIEW AND META-ANALYSIS
Guzelant G., Yurttas B., Esatoglu S. N., Hamuryudan V., Yazici H., Hatemi G.
19th International Vasculitis and ANCA Workshop, Pennsylvania, Amerika Birleşik Devletleri, 7 - 10 Nisan 2019, cilt.58, ss.139, (Özet Bildiri)
2018
20185. Could neurological involvement in Behcet's Disease occur atypically?
Siva A., Esatoglu S. N., Uygunoglu U., Ozguler Y., Hatemi G., Tutuncu M., et al.
70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Şili, 21 - 27 Nisan 2018, cilt.90, (Özet Bildiri)
2017
20176. PAPULOPUSTULAR LESIONS ACCORDING TO AGE, SEX AND LOCALIZATION IN BEHCET'S SYNDROME PATIENTS COMPARED HEALTHY AND DISEASED CONTROLS
Kutlubay Z., Ozguler Y., Hatemi G., Tascilar K., Mat C., Yazici H.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.90-91, (Özet Bildiri)
2017
20177. IDENTIFYING CORE DOMAINS FOR BEHCETS SYNDROME TRIALS BY A DELPHI EXERCISE
Meara A. S., Ozguler Y., Mahr A., Direskineli H., Gül A., Yazici Y., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.95, (Özet Bildiri)
2017
20178. RELATIONSHIP BETWEEN MENSTRUATION AND SYMPTOMS OF BEHCET'S SYNDROME
Guzelant G., Ozguler Y., Esatoglu S. N., Karatemiz G., Ozdogan H., Yurdakul S., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.92, (Özet Bildiri)
2017
20179. EARLIER USE OF INFLIXIMAB FOR THE UVEITIS OF BEHCET'S SYNDROME APPEARS TO BE ASSOCIATED WITH BETTER OUTCOME
Guzelant G., Guzelant G., Ucar D., Hatemi G., Ozyazgan Y., Esatoglu S. N., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.94, (Özet Bildiri)
2017
201710. CAN WE DIFFERENTIATE TAKAYASU'S ARTERITIS FROM ATHEROSCLEROSIS USING CAROTID ARTERY DOPPLER USG?
Seyahi E., Esatoglu S. N., Ugurlu S., Keskin F. E., Cetinkaya F., Melikoglu M., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.46-47
2017
201711. SYSTEMATIC REVIEW ON THE TREATMENT OF SKIN, MUCOSA AND JOINT INVOLVEMENT OF BEHCET'S SYNDROME INFORMING THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF BEHCET'S SYNDROME
Leccese P., Ozguler Y., Christensen R., Esatoglu S. N., Olivieri I., Yazici H., et al.
18th International Vasculitis and ANCA Workshop, Tokyo, Japonya, 25 - 28 Mart 2017, cilt.56, ss.89, (Özet Bildiri)
2013
201312. Systems Approach To The Study Of the Microbiome and Inflammatory Pathways In Oral Ulcer Tissue From Patients With Active Behcet's Syndrome (BS)
Sibley C., Hatemi G., Yazici Y., Liu Y., Brooks S., Yazici H., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201313. Venous Claudication Is A Severe and Frequent Symptom In BEHCET'S Syndrome
Ugurlu S., Seyahi E., Oktay V., Yigit Z., Kucukoglu S., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201314. Infliximab For Sight-Threatening and Refractory Uveitis Of Behcet's Syndrome
Hamuryudan V., Hatemi G., Ozyazgan Y., Ucar D., Yurdakul S., Seyahi E., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201315. An Outcome Survey Of 40 Patients With Budd-Chiari Syndrome Due To BEHCET'S Syndrome Followed By A Single Center
Seyahi E., Ugurlu S., Caglar E., Kantarci F., Sonsuz A., Yurdakul S., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201316. Apremilast For The Treatment Of Behcet's Syndrome: A Phase II Randomized, Placebo-Controlled, Double-Blind Study
Hatemi G., Melikoglu M., Tunc R., KORKMAZ C., ÖZTÜRK B. T., Mat C., et al.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201317. Fertility In Behcet's Syndrome: Structured Interview In A Multidisciplinary Center
Saygin C., Uzunaslan D., Hatemi G., Tascilar K., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2013
201318. A CT Evaluation Of Pulmonary and Cardiac Lesions In BEHCET'S Syndrome Patients Without Pulmonary Symptoms
Seyahi E., Olgun D. C., Ugurlu S., Hanci I., Takahashi R., Yazici H.
77th Annual Meeting of the American-College-of-Rheumatology / 48th Annual Meeting of the Association-of-Rheumatology-Health-Professionals, California, Amerika Birleşik Devletleri, 25 - 30 Ekim 2013, cilt.65, (Özet Bildiri)
2012
201219. Characteristics, Treatment and Outcome of Gastrointestinal Involvement in Behcet's Syndrome: Experience in A Dedicated Center
Hatemi I., Hatemi G., Erzin Y., Celik A. F., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)
2012
201220. Aortic and Coronary Calcifications in Takayasu Arteritis
Seyahi E., Ucgul A., Ugurlu S., Akman C., Olgun D. C., Yurdakul S., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64
2012
201221. The Clinical Course of the Acute Deep Vein Thrombosis of the Legs in Behcet's Syndrome.
Ozguler Y., Melikoglu M., Cetinkaya F., Ugurlu S., Seyahi E., Tascilar K., et al.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)
2012
201222. Further Evidence On Biased Cancer Risk Estimation in Studies Comparing A Subpopulation to the General Population.
Tascilar K., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64
2012
201223. Effect of Colchicine On Cholesterol Levels in Patients with Familial Mediterranean Fever and Behcet's Syndrome
Ugurlu S. L., Seyahi E., Hanci I., Ozdogan H., Masatlioglu-Pehlivan S., Yazici H.
Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) and Association-of-Rheumatology-Health-Professionals (ARHP), Washington, Kiribati, 9 - 14 Kasım 2012, cilt.64, (Özet Bildiri)
2011
201124. Management and Prognosis of Non-Pulmonary Large Arterial Disease in Behcet's Syndrome: A Reappraisal of 25 Patients From a Single Center
Tuzun H., Seyahi E., Arslan C., Hamuryudan V., Besirli K., Yazici H.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)
2011
201125. The "Table-1 p Value" Issue; Baseline Group Comparison Is Inappropriately Omitted in Non-Randomized Studies
Tascilar K., Atac E., Esen F., Yazici H.
75th Annual Scientific Meeting of the American-College-of-Rheumatology (ACR) / 46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals (ARHP), Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)
2011
201126. A Possible Source of Error in the Method of Cancer Risk Estimation in Patients with Rheumatoid Arthritis
Yazici H., Tascilar K., Yazici Y., Kiroglu G., Duransoy L., Erar A.
75th Annual Scientific Meeting of the American-College-of-Rheumatology/46th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Illinois, Amerika Birleşik Devletleri, 4 - 09 Kasım 2011, cilt.63, (Özet Bildiri)
2011
201127. THE FREQUENCY OF FIBROMYALGIA IS NOT INCREASED AMONG NURSES
Yurdakul S., Findikoglu S. Y., Hatemi G., Suzen S., Yazici H.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
2011
201128. WORK DISABILITY IN BEHCET'S SYNDROME
Hatemi G., Hamuryudan V., Tascilar K., Ugurlu S., Yazici H.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
2011
201129. ANTI-TNF THERAPY IN SEVERE UVEITIS OF BEHCET'S SYNDROME: REPORT OF 27 PATIENTS
Ugurlu S., Hamuryudan V., Ozyazgan Y., Seyahi E., Hatemi G., Yurdakul S., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
2011
201130. COLCHICINE DOES NOT DECREASE THE NEED FOR IMMUNOSUPPRESSIVE USE AT LONG TERM IN BEHCET'S SYNDROME
Hamuryudan V., Hatemi G., Yurdakul S., Mat C., Tascilar K., Ozyazgan Y., et al.
Conference on Excellence in Rheumatology, İstanbul, Türkiye, 17 - 19 Şubat 2011, cilt.50, (Özet Bildiri)
2010
201031. V617F JAK2 mutations are not associated with thrombosis among patients with Behçet’s Syndrome.
AR C., HATEMİ G., EKİZOĞLU ERATAK S., SAÇLI S., BİLGEN H., BUYRU A. N., et al.
14th International Conference on Behçet`s Disease, Londra, Birleşik Krallık, 8 - 10 Temmuz 2010, (Özet Bildiri)
2009
200932. Kronik Hastalığı Olmayan Yaşlı Topluluğunda İmmün Gen Belirteçlerinin Analizleri: IL-6, IL-10 ve TNF-A Sonuçları
TAHİR TURANLI E., ERDİNÇLER Ü. D., ÇURGUNLU A., BOLAYIRLI İ. M., SEYAHİ E., BEĞER T., et al.
Akademik Geriatri Kongresi,, Antalya, Türkiye, 20 - 24 Mayıs 2009, ss.158-159, (Tam Metin Bildiri)
2008
200833. Tümör Nekroz Faktörü Alfa Antogonistleri ile Tedavi Quantıferon-TB Gold Testinin sonucunu etkilemez
HATEMİ G., MELİKOĞLU M., ÖZBAKIR F., Batumlu M., Taşçılar K., Çevirgen D., et al.
IX.Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2008, ss.120, (Tam Metin Bildiri)
2008
200834. Effect of immunosuppressive treatment on skin pathergy reaction in Behcet's disease
Tascilar K., Melikoglu M., Baran A., Gogus F., Hatemi G., Yazici H.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)
2008
200835. Quantiferon-TB gold blood test in rheumatoid arthritis patients using TNF-alpha antagonists
Hatemi G., Melikoglu M., Tascilar K., Batumlu M., Ozbakir F., Cevirgen D., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58, (Özet Bildiri)
2008
200836. Large vessel involvement in Behcet's syndrome: A retrospective survery
Melikoglu M., UĞURLU S., Tascilar K., Caglar E., Seyahi E., Hamuryudan V., et al.
72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, San-Francisco, Kostarika, 24 - 29 Ekim 2008, cilt.58
2007
200737. Yaşlanma ve MEFV Mutasyonları",
TAHİR TURANLI E., BEGER T., ERDİNÇLER Ü. D., ÇURGUNLU A., KARAMAN S., KARACA E., et al.
XIX Ulusal İmmunoloji Kongresi, Antalya, Türkiye, 21 - 24 Kasım 2007, ss.218
2006
200638. TNF inhibitors (TNFi): Useful additional therapy to methotrexate (MTX) in rheumatoid arthritis patients with severe disease.
Yazici Y., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)
2006
200639. Alternative treatments in colchicine-resistant patients with familial mediterranean fever (FMF).
Seyahi E., Ozdogan H., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54
2006
200640. Behcet's syndrome (BS) patients with acne and arthritis (BS-AA) have more enthesopathy than BS patients without acne and arthritis (BS-nonAA).
Hatemi G., Fresko I., Tascilar K., Yazici H.
70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals, Washington, Kiribati, 10 - 15 Kasım 2006, cilt.54, (Özet Bildiri)
2004
200441. Differences in the frequency of 52kDa and 60kDa anti-SSA/Ro antibodies among primary Sjögren’s Syndrome. Systemic Lupus Eryhematosus and Systemic Lupus Erythematosus with secondary Sjögren’s Syndrome
ÖZBAKIR F., FRESKO İ., SEYAHİ E., Masatlıoğlu S., YAZICI H.
Twelfth International Congress of Histochemistry and Cytochemistry meeting jointly with The Histochemical Society ICHC 2004, San Diago, Amerika Birleşik Devletleri, 24 - 28 Temmuz 2004, cilt.12, ss.3, (Özet Bildiri)
2003
200342. Anti-Sacchcaromyces cerevisiae antibodies(ASCA) in Behçet’s
FRESKO İ., UĞURLU S., ÖZBAKIR F., ÇELİK A. F., YURDAKUL S., YAZICI H.
Annual European Congress of Rheumatology. EULAR 2003, Lizbon, Portekiz, 18 - 21 Haziran 2003, cilt.62, sa.1, ss.209
2003
200343. Fibrinolytic activity and d-dimer levels of in Behcçet’s Syndrome
YURDAKUL S., Hekim D. N., SOYSAL T., MELİKOĞLU M., ÖZBAKIR F., FRESKO İ., et al.
Annual European Congress of Rheumatology.EULAR 2003, Lizbon, Portekiz, 18 - 21 Haziran 2003, cilt.62, sa.1, ss.210-211, (Özet Bildiri)
2003
200344. The characteristic of anti-Topoisomerase I antibodies in Systemic Lupus Erythematosus(SLE) patients
ÖZBAKIR F., FRESKO İ., YILMAZER S., YAZICI H.
15th european immunology congress efis2003, Rodos, Yunanistan, 8 - 12 Haziran 2003, cilt.15, ss.86, (Özet Bildiri)
2002
200245. Absence of ANCA in Behçet’s Syndrome with Large Vessel Involvement
Tunç R., ÖZBAKIR F., Çağlayan A., Altıparmak M., FRESKO İ., YAZICI H.
Annual European Congress of Rheumatology. EULAR 2002, Stockholm, İsviçre, 12 - 15 Haziran 2002, cilt.61, sa.1, ss.215
1999
199946. Myeloperoxidase activity of Neutrophils Exposed to Monosodium Ürate in Behçets Syndrome
MELİKOĞLU M., ÖZBAKIR F., Hekim C., Hekim D. N., YAZICI H., FRESKO İ., et al.
The fifth Korea;Turkey Joint Meeting of Behçet”s Disease, İstanbul, Türkiye, 06 Eylül 1999, cilt.1, ss.18, (Özet Bildiri)
0
047. Changes in Blood and Haemoreological Parameters in Behcet Disease
ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
International Congress on Thrombosis Research, Türkiye, ss.569-570, (Özet Bildiri)
1998
199848. Behçet Hastalığında Serum Çinko, Bakır ve Demir Elementleri Değişiminin Araştırılması
ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
1.Ulusal Çinko Kongresi, Eskişehir, Türkiye, 1 - 04 Eylül 1998, ss.743-748, (Tam Metin Bildiri)
1996
199649. Vascular involvement in Behcet’s Syndrome: A controlled survey with doppler ultrasonography and CRP, FVIIIRg, ACE levels
HAMURYUDAN V., AKMAN C., ÖZBAKIR F., TÜZÜN K. H., Hızlı U., Ersavash G., et al.
VIth İnternational Conference on Behcet’s Disease, Tunus, Tunus, 10 - 11 Ekim 1996, cilt.7, ss.545, (Özet Bildiri)
1996
199650. Anti-mycobacterial antibodies in Behçet’s syndrome.
MERT A., ÖZTÜRK R., Sipahi S., FRESKO İ., Aslan M., HAMURYUDAN V., et al.
VIIth International Conference on Behçet’s disease, Tunis, Tunus, 10 - 11 Ekim 1996, ss.25, (Özet Bildiri)
1996
199651. Anti-Scl70 Antibodies in Systemic Lupus Eritematosus(SLE).
YAZICI H., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., HAMURYUDAN V., Hızlı U.
IXth EULAR Syposium of Rheumatology, Madrid, İspanya, 7 - 10 Ekim 1996, cilt.25, sa.1, ss.63
0
052. Behçet Hastalığında Kan Parametreleri ve Hemoreolojik Parametrelerin Değişimi
ÖZDEMİR S., DURSUN Ş., HAMURYUDAN V., YAZICI H.
VIII. Ulusal Biyofizik Kongresi,, Kocaeli, Türkiye, ss.10
1994
199453. Lymphocytotoxıc Antibodies in Children: Comparison of Healthy with Diseased States.
Çelebi D. A., KASAPÇOPUR Ö., ÖZBAKIR F., ARISOY N., YAZICI H., ÖZDOĞAN A. H.
Second European Conference on Pediatric Autoimmune and Rheumatic Diseases., Pavia, İtalya, 7 - 10 Eylül 1994, cilt.12, sa.10, ss.120, (Özet Bildiri)
1993
199354. Sm And Ro Autoantibodies in Turkish Patients with SLE and RA
Moral,MD F., ÖZBAKIR F., Çakır P. N., ÖZDOĞAN A. H., YAZICI H., YURDAKUL S., et al.
XVIIIth ILAR Congress of Rheumatology, Barselona, İspanya, 4 - 09 Temmuz 1993, cilt.20, sa.1, ss.126, (Özet Bildiri)
1993
199355. Correlation between disease actıvıty and ınterleukin-6 blood levels in systemic lupus erythematosuss, a comparative study with C3, CRP and Fibrinojen
Çakır P. N., Guerne P., Moral,MD F., ÖZBAKIR F., YURDAKUL S., ÖZDOĞAN A. H., et al.
XVIIIth ILAR Congress of Rheumatology, Barselona, İspanya, 4 - 09 Temmuz 1993, cilt.20, sa.1, ss.528
1992
199256. Sağlıklı Çocuklarda Antinükleer Antikor ve Romatoid Faktör Sıklığı
KASAPÇOPUR Ö., ÖZDOĞAN A. H., ÖZBAKIR F., INGÖL H., SARP A., YAZICI H.
VIII. Ulusal Romatoloji Kongresi, İstanbul, Türkiye, 7 - 11 Eylül 1992, cilt.7, ss.13, (Özet Bildiri)
1992
199257. Sistemik Lupus Eritematosus’da Hastalık Aktivitesi ile İnterlökin-6 Değerleri Arasındaki İlişki
Çakır P. N., Moral, U. F., ÖZBAKIR F., VISCHER T., Guerne P., YAZICI H.
VIII.Ulusal Romatoloji Kongresi, İstanbul, Türkiye, 7 - 11 Eylül 1992, cilt.8, ss.19, (Özet Bildiri)
1992
199258. Türk Sistemik Lupus Eritematosus ve Romatoid Artrit’lilerinde Anti-Ro ve Anti-Sm Antikorları
Moral, U. F., ÖZBAKIR F., Çakır P. N., HAMURYUDAN V., YURDAKUL S., ÖZDOĞAN A. H., et al.
VIII. Ulusal Romatoloji Kongresi, İstanbul, Türkiye, 7 - 11 Eylül 1992, cilt.8, ss.14, (Özet Bildiri)
1992
199259. Frequency of Antinuclear Antibodies and Rheumatoid Factor in Healthy Children
KASAPÇOPUR Ö., ÖZDOĞAN A. H., ÖZBAKIR F., INGÖL H., SARP A., YAZICI H.
Parague International Pediatric Rheumatology Symposium(Pipers), Prague, Çek Cumhuriyeti, 26 - 29 Nisan 1992, cilt.4, ss.50, (Özet Bildiri)
1991
199160. Lymphocytotoxic Antibodies (LCA) in Family Members of Patients with Behcet’s Syndrome (BS)
Günaydın İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.
12th European Congress of Rheumatology, Budabeşte, Macaristan, 30 Haziran - 06 Temmuz 1991, cilt.32, ss.135
1990
199061. Behcet Hastaları ve Aile Bireylerinde Lenfositotoksik Antikorlar
Günaydın, U. İ., YAZICI H., ÖZBAKIR F., HAMURYUDAN V., YURDAKUL S.
VII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 30 Ekim - 01 Kasım 1990, cilt.6, ss.44
1990
199062. Behçet Sendromlu Tek Yumurta İkizleri
HAMURYUDAN V., YURDAKUL S., Hekim D. N., ÖZBAKIR F., YAZICI H.
VII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 30 Ekim - 01 Kasım 1990, cilt.6, ss.30, (Özet Bildiri)
1987
198763. HLA antigens in recurrent oral ulceration; Evidence aganist a common disease spectrum with Behçet’s syndrome
ÖZBAKIR F., YAZICI H., MAT M. C., TÜZÜN Y., YURDAKUL S., YILMAZER S.
XIth European Congress of Rheumatology Congress, Atina, Yunanistan, 28 Haziran - 04 Temmuz 1987, cilt.5, sa.2, ss.140
1986
198664. Rekkuran Aftöz Stomatitde Doku Antijenler
ÖZBAKIR F., MAT M. C., YURDAKUL S., TÜZÜN Y., YAZICI H.
VIII. Ulusal İmmünoloji Kongresi, İstanbul, Türkiye, 30 - 31 Ekim 1986, cilt.7, ss.9, (Özet Bildiri)
1986
198665. Romatoid Artritte Pulse Siklofosfamid Tedavisi
Dede U. H., YURDAKUL S., ÖZBAKIR F., YAZICI H.
VIII. Ulusal İmmünoloji Kongresi, İstanbul, Türkiye, 30 Eylül - 01 Kasım 1986, cilt.1, ss.28, (Özet Bildiri)
1985
198566. Sex factor and Behçet's syndrome
YAZICI H., HEKİM N., TÜZÜN Y., SERDAROĞLU S., Kotoğyan A., ÖZ F., et al.
INTERNATIONAL CONFERENCE OF BEHÇET'S DISEASE, Londra, Birleşik Krallık, 5 - 06 Eylül 1985, ss.205-206
1985
198567. Total lymphoid irradiation for the treatment of intractable Behçet's syndrome
YURDAKUL S., YAZICI H., Müftüoğlu A., OKKAN S., TURKAN S., UZEL R., et al.
INTERNATIONAL CONFERENCE ON BEHÇET'S DISEASE, Londra, Birleşik Krallık, 5 - 06 Eylül 1985, ss.307-308, (Tam Metin Bildiri)
1982
198268. The prevalence of HLA B27 is Increased in Rheumatoid Arthritis in Turkey
YAZICI H., ÖZBAKIR F., YURDAKUL S., Müftüoğlu P. A.
5th. European İmmunology Meeting, İstanbul, Türkiye, 1 - 04 Haziran 1982, cilt.5, sa.33, ss.213, (Özet Bildiri)
1981
198169. The prevalence of HLA B5 in recurrent oral ulceration versus Behçet’s disease in Turkey 16-18 March1981
ÖZBAKIR F., YAZICI H., TÜZÜN Y., ÖZDOĞAN A. H., Müftüoğlu P. A.
European Histocompability Training Conference, Strasbourg,, Fransa, 16 - 18 Mart 1981, sa.1, ss.94, (Özet Bildiri)
Kitaplar
2014
20141. Behçet’s syndrome
SEYAHİ E., HATEMİ G., FRESKO İ., MELİKOĞLU M., YAZICI H.
Oxford Textbook of Vasculitis (3 ed.), Gene V. Ball, Barri J. Fessler, and S. Louis Bridges, Jr., Editör, Oxford University Press, London , Londra, ss.1-2, 2014
1996
19962. Behçet's syndrome with emphasis on clinical genetics and mortality
YAZICI H., ÇİÇEK B., Başaran G., HAMURYUDAN V., ÇAKIR N., DIMITRIATRIS I., et al.
The Vasculitides, BM Ansell, PA Bacon, JT Lie, H. Yazici, Editör, Chapman & G.K. Hall & Co., London, ss.199-206, 1996
Desteklenen Projeler
2007 - 2011
2007 - 2011İSTANBUL'DA YAŞAYAN ERMENİ KÖKENLİ VE TÜRK VATANDAŞLARDA MEFV GEN MUTASYON VE HLA B51 SIKLIĞI
Yükseköğretim Kurumları Destekli Proje , BAP Diğer
YAZICI H. (Yürütücü)